The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Full Deal Summary

WuXi NextCODE Genomics (genomic data platform) raised $200mm in its Series C financing round. The round included participation from a consortium led by the Ireland Strategic Fund ($70mm), along with existing investors Temasek, Yunfeng Capital and Sequoia Capital. WuXi plans to use the proceeds to expand operations at Genomics Medicine Ireland (GMI), which the company recently acquired, and to speed up enrollment and sequencing of the entire genome of 400k people across Ireland for use in precision medicine. To date, WuXi has raised over $450mm in venture funding including a $240mm Series B round last year.


+ Show All | – Hide All

Financials


Click a figure for comparable deals.

Overview
Potential Deal Value $200.00mm
Transactions 1 of 1 (11/2018)
Round # 3
Funding Stage Additional Round
Equity $200.00mm
Total Line Value $200.00mm
Gross Proceeds $200.00mm
Investors Sequoia Capital
Temasek Holdings
Yunfeng Capital

Company Information


Click a keyword for comparable companies.

WuXi PharmaTech Inc. www.wuxipharmatech.com | Ticker: WX
View Company Profile | View Company Deals
Company Location Worldwide
Asia
China
Industry Biotechnology
Drug Discovery Tools
ADMET
Contract Research, Toxicology Testing-CRO
Laboratory Testing Services
Medical Devices
Pharmaceuticals
Services
Ownership Private
Therapeutic Area(s) of Focus Non-Specific
Alias(es) WuXi PharmaTech Co. Ltd.
WuXi AppTec Co. Ltd.

WuXi NextCODE Genomics
a division of WuXi PharmaTech Inc.
www.wuxinextcode.com
View Company Profile | View Company Deals
Company Location Worldwide
North America
USA
MA
Industry Biotechnology
Drug Discovery Tools
Bioinformatics
In Vitro Diagnostics
Molecular Diagnostics & Genetic Testing
Research, Analytical Equipment & Supplies
Services
Ownership Private
Therapeutic Area(s) of Focus Non-Specific
Alias(es) NextCODE Health LLC